Company Profiles

driven by the PitchBook Platform

ArmaGen Technologies

Description

Provider of a technology platform for the blood-brain barrier problem. The company's technology produces IgG fusion proteins formed by fusion of a recombinant protein therapeutic.

2001

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$18.6M

Latest Deal Amount

$17M

Total Amount Raised

Description

Provider of a technology platform for the blood-brain barrier problem. The company's technology produces IgG fusion proteins formed by fusion of a recombinant protein therapeutic.

Website:

www.armagen.com

Formerly Known As

Neurogene Technologies

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Biotechnology

Primary Office

26679 Agoura Road Suite 100 Calabasas, CA 91302United States +1 (818) 252-8200
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore ArmaGen Technologies's full profile, request a free trial.

ArmaGen Technologies Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

ArmaGen Technologies Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

ArmaGen Technologies Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Boehringer Ingelheim Venture FundCorporate Venture CapitalMinority000 0000000 0000
Mitsui Global InvestmentCorporate Venture CapitalMinority000 0000000 0000
ShireCorporationMinority000 0000000 0000
Takeda VenturesCorporate Venture CapitalMinority000 0000000 0000
U.S. Department of Health and Human ServicesGovernment000 0000000 0000
Boehringer Ingelheim Venture Fund Corporate Venture Capital
Mitsui Global Investment Corporate Venture Capital
Shire Corporation
Takeda Ventures Corporate Venture Capital
U.S. Department of Health and Human Services Government

ArmaGen Technologies Executive Team (10)

NameTitleBoard
Seat
Contact
Info
Mathias Schmidt Ph.DPresident, Board Member & Chief Executive Officer
James Callaway Ph.DChief Executive Officer & Board Member
William Pardridge MDFounder, Chief Scientific Officer & Board Member
John EnriquezDirector of Clinical Operations
Ruben Boado Ph.DCo-Founder & Vice President, Research & Development
Mathias Schmidt Ph.D President, Board Member & Chief Executive Officer
James Callaway Ph.D Chief Executive Officer & Board Member
William Pardridge MD Founder, Chief Scientific Officer & Board Member
John Enriquez Director of Clinical Operations
Ruben Boado Ph.D Co-Founder & Vice President, Research & Development

ArmaGen Technologies Board Members (11)

NameRepresentingRoleSinceContact
Info
Brian PiperBoard Member000 0000
Deanna PetersenShireVice President of Business Development000 0000
Graeme Martin Ph.DTakeda VenturesPresident & Chief Executive Officer000 0000
James Callaway Ph.DArmaGen TechnologiesChief Executive Officer & Board Member000 0000
Martin Heidecker Ph.DBoehringer IngelheimBoard Member000 0000
Brian Piper Board Member
Deanna Petersen Vice President of Business Development Shire
Graeme Martin Ph.D President & Chief Executive Officer Takeda Ventures
James Callaway Ph.D Chief Executive Officer & Board Member ArmaGen Technologies
Martin Heidecker Ph.D Board Member Boehringer Ingelheim
Request full access to PitchBook